Analysts at Goldman Sachs issued more cautious comments on Pharmasset, Inc. (Nasdaq: VRUS), which has surged recently after an bullish ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE